Presentation is loading. Please wait.

Presentation is loading. Please wait.

Jamal H. Carter, Samantha N. McNulty, Patrick J. Cimino, Catherine E

Similar presentations


Presentation on theme: "Jamal H. Carter, Samantha N. McNulty, Patrick J. Cimino, Catherine E"— Presentation transcript:

1 Targeted Next-Generation Sequencing in Molecular Subtyping of Lower-Grade Diffuse Gliomas 
Jamal H. Carter, Samantha N. McNulty, Patrick J. Cimino, Catherine E. Cottrell, Jonathan W. Heusel, Katinka A. Vigh-Conrad, Eric J. Duncavage  The Journal of Molecular Diagnostics  Volume 19, Issue 2, Pages (March 2017) DOI: /j.jmoldx Copyright © 2017 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

2 Figure 1 Schematic flow chart summarizing the diagnostic standing of various recurrent alterations in lower-grade gliomas according to the 2016 World Health Organization central nervous system tumor classification. The Journal of Molecular Diagnostics  , DOI: ( /j.jmoldx ) Copyright © 2017 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

3 Figure 2 Sequencing results organized by IDH1/2 and next-generation sequencing–based 1p/19q codeletion status. Variants displayed are those identified in genes that are either recurrently mutated or otherwise clinically actionable in lower-grade gliomas. Single-nucleotide polymorphisms (single-nucleotide variations in >1% of the population) were excluded. See Variant Annotation and Reporting for details. Boxes with multiple colors indicate more than one variant present. mut, mutant; WT, wild type. The Journal of Molecular Diagnostics  , DOI: ( /j.jmoldx ) Copyright © 2017 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

4 Figure 3 Heat map schematic of the next-generation sequencing–based copy number profiles of chromosomes 1 and 19 relative to the locations of the fluorescence in situ hybridization (FISH) probes used in conventional testing. Cases are grouped by IDH1/2 and next-generation sequencing–based 1p/19q codeletion status. Percentages indicate the variant allele frequency (VAF) of IDH1/2 mutants (mut), when present. WT, wild type. The Journal of Molecular Diagnostics  , DOI: ( /j.jmoldx ) Copyright © 2017 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions


Download ppt "Jamal H. Carter, Samantha N. McNulty, Patrick J. Cimino, Catherine E"

Similar presentations


Ads by Google